21 C.F.R. PART 50--PROTECTION OF HUMAN SUBJECTS
TITLE 21--Food and Drugs
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER A--GENERAL
PART 50--PROTECTION OF HUMAN SUBJECTS
Subpart A--GENERAL PROVISIONS
Subpart B--INFORMED CONSENT OF HUMAN SUBJECTS
|
General requirements for informed consent.
|
|
|
Exception from general requirements.
|
|
|
Exception from informed consent requirements for emergency research.
|
|
|
Elements of informed consent.
|
|
|
Documentation of informed consent.
|
|
Subpart C--[RESERVED]
Subpart D--ADDITIONAL SAFEGUARDS FOR CHILDREN IN CLINICAL INVESTIGATIONS
|
Clinical investigations not involving greater than minimal risk.
|
|
|
Clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects.
|
|
|
Clinical investigations involving greater than minimal risk and no prospect of direct benefit to individual subjects, but likely to yield generalizable knowledge about the subjects' disorder or condition.
|
|
|
Clinical investigations not otherwise approvable that present an opportunity to understand, prevent, or alleviate a serious problem affecting the health or welfare of children.
|
|
|
Requirements for permission by parents or guardians and for assent by children.
|
|